These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8222900)
1. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients. Gao L; Xu GZ; Yin WB; Yan JH; Cai WM; Gu XZ Chin Med J (Engl); 1993 Jun; 106(6):467-70. PubMed ID: 8222900 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792 [TBL] [Abstract][Full Text] [Related]
4. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma]. Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943 [TBL] [Abstract][Full Text] [Related]
5. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients]. Cao X; Chen K; He Z Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969 [TBL] [Abstract][Full Text] [Related]
6. Reirradiation of locally recurrent nasopharyngeal carcinoma. Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194 [TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease. Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806 [TBL] [Abstract][Full Text] [Related]
9. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420 [TBL] [Abstract][Full Text] [Related]
10. [Endocavitary curietherapy of tumors of the rhinopharynx after external radiotherapy]. Latini P; Panizza BM; Checcaglini F; Maranzano E; Aristei C; Perrucci E Radiol Med; 1991; 82(1-2):143-6. PubMed ID: 1896567 [TBL] [Abstract][Full Text] [Related]
11. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome. Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885 [TBL] [Abstract][Full Text] [Related]
12. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955 [TBL] [Abstract][Full Text] [Related]
13. Intracavitary radiation treatment of nasopharyngeal carcinoma by the high dose rate afterloading technique. Zhang YW; Liu TF; Fi CX Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):315-8. PubMed ID: 2921132 [TBL] [Abstract][Full Text] [Related]
14. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: treatment techniques and results. Maalej M; Ben Ammar CN; Kochbati L; Frikha H; Hentati D; Gargouri W; Besbes M Cancer Radiother; 2007 May; 11(3):117-21. PubMed ID: 17293150 [TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}. Leung TW; Wong VY; Sze WK; Lui CM; Tung SY Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917 [TBL] [Abstract][Full Text] [Related]
16. High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study. Malde R; Agarwal JP; Laskar SG; Gupta T; Dinshaw K Bull Cancer; 2005 Jul; 92(7):E45-50. PubMed ID: 16122998 [TBL] [Abstract][Full Text] [Related]
17. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
18. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110 [TBL] [Abstract][Full Text] [Related]
20. [Brachytherapy with (192)Iridium in the treatment of recurrent nasopharyngeal carcinoma]. Fischer M; Stüben G; Stuschke M; Jahnke K Laryngorhinootologie; 2002 Feb; 81(2):106-10. PubMed ID: 11914947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]